TheStreet.com RealMoney
Option Traders See a Bottom in PMI Group

By Rebecca Darst

About this article:
Earnings carnage continued in the insurance segment today, with PMI Group reporting lower profits and hits on its investment portfolio. Early data from TradeAlerts suggests that 95% of the option activity in the country's second-largest mortgage insurer weighs in on the bullish end of the sale, with buying interest at the December 5.0 call strike at 35 cents per contract propelling volume to 14 times the normal level. This may simply be an indication of a hard-won bottom for a stock that has lost more than three-quarters of its value this year. Unusual option activity manifested today in the form of Martek Biosciences, a maker of food products and supplements based on microalgae. While shares have held up respectably well this year with 5% positive returns, the stock is in a multiyear downtrend, and short interest has risen this year to constitute more than one-quarter of...

You have just read the beginning of a premium article from our RealMoney Service. To read the rest of this article and sign up for a FREE trial please click below.

ACCESS STORY & START A FREE 14-Day Trial
Or, call us at 1-866-321-TSCM (8726) Monday-Friday, 8 a.m.-6 p.m. ET.
Outside the U.S. and in Canada, call 1-212-321-5200.



Already a RealMoney subscriber? LOG IN.
Username:   Password:
Forgot your Password? Click here

Page data is submitted securely.




If you choose a 14-day free trial of RealMoney and you do NOT call to cancel within those 14 days, you will pay $129.95 — a $100 savings off the regular annual subscription price of $229.95. Unless you cancel before the end of that year, your subscription will automatically renew for another year at the then-current subscription price.

Offer applies only to new annual subscriptions, and is subject to change at any time. Void where prohibited.

If you choose a monthly subscription, you pay $34.95 per month. You will be notified if the current monthly rate of $34.95 changes at any time in the future.

TheStreet.com is a publisher. None of the contributors or their affiliates will provide you with personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. From time to time, any or all of the contributors or their affiliates may hold positions in securities mentioned and they may trade for their own accounts. In cases where the position is held at the time of publication, appropriate disclosure is made.

© TheStreet.com, Inc., 14 Wall Street, 15th Floor, New York, NY 10005.